Tag: cat allergy

Circassia abandons allergy programme after trial failure

by Selina McKee | Apr 18, 2017 | News | 0

British biotech Circassia has announced the death of its allergy programme following a second key trial failure, choosing to focus all of its efforts on its respiratory business instead.

Circassia’s cat allergy drug fails to hit trial targets

by Selina McKee | Jun 21, 2016 | News | 0

Shares in UK biotech Circassia have plummeted after its flagship experimental cat allergy drug failed to hit targets in a Phase III trial.

Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
Ipsen announces new data on Dysport in neurological disease
PMGroup Worldwide Ltd welcomes MAD World Summit
Argenx receives review from FDA for VYVGART in seronegative gMG

PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN

E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999

Tag: cat allergy

Circassia abandons allergy programme after trial failure

Circassia’s cat allergy drug fails to hit trial targets

News alerts

Latest content

Contact details

Download our apps

Content

Connect

Legal